Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease. Bateman RJ, Smith J, Donohue MC, Delmar P, et al. N Engl J Med 2023;389:1862-1876.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bateman RJ, Smith J, Donohue MC, Delmar P, et al. Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease. N Engl J Med 2023;389:1862-1876.
PMID: 37966285